ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685005 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685005; 2) Community: the network communities that were significantly associated with the response to NSC 685005; 3) Molecule: the relationships between components within communities and NSC 685005; 4) MDR: the compounds that were significantly associated with the NSC 685005.

NSC Compound Enrichment Correlation
NSC 153325 Null 0.0382675857669585 0.2760667
NSC 175630 Toyocamycin, 6-amino- 0.0382675857669585 0.33263397
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0382675857669585 0.24785858
NSC 3053 Actinomycin D 0.0382675857669585 -0.093039014
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0382675857669585 -0.17556926
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0382675857669585 0.096891253
NSC 338947 Clomesone 0.0382675857669585 -0.024342908
NSC 381866 BAFILOMYCIN DERIV. 0.0382675857669585 0.1063416
NSC 64798 Null 0.0382675857669585 0.24545345
NSC 651861 Null 0.0382675857669585 -0.076944921
Total:97  Current:81    [First] [Prev] [Next] [Last]